Abstract
A sensor design and sensing method based on plasmonic–photonic interactions that occur when a nanocavity array is embedded in a 3D tapered nanocup plasmonic substrate are reported. This device enables highly sensitive detection of refractive index changes based on changes to the transmission peak intensity without shift in the resonance wavelength. Unlike conventional plasmonic sensors, there is a consistent and selective change in the transmission intensity at the resonance peak wavelength with no spectral shift. In addition, there are wavelength ranges that show no intensity change, which can be used as reference regions. The fabrication and characterization of the plasmonic nanocavity sensor are described and also advanced biosensing is demonstrated. Simulations are carried out to better understand the plasmon–photonic coupling mechanism. This nanocavity plasmonic sensor design has a limit of detection of 1 ng mL−1 (5 × 10−12m) for the cancer biomarker carcinoembryonic antigen (CEA), which is a significant improvement over current surface plasmon resonance systems, and a dynamic range that is clinically relevant for human CEA levels.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
